Prostate Specific Membrane Antigen Positron Emission Tomography/Computed Tomography (PSMA-PET/CT) has increased the sensitivity and specificity of imaging to identify metastatic prostate cancer in the group of patients with early biochemical recurrence when compared to conventional imaging. In patients who develop biochemical recurrence of prostate cancer following surgical resection, salvage lymph node dissection may reduce prostate specific antigen (PSA) levels and delay the time for commencement of systemic therapies. However, PLND may be an anatomically and technically difficult procedure, particularly with small metastatic diseases which can be problematic for intra-operative identification. We describe the technique using PSMA-PET imaging to pre-operatively localise areas of low-volume nodal metastatic disease with hookwire to allow targeted lymph node dissection with direct visualisation and palpation to ensure adequate clearance of involved nodes.
World journal of urology. 2018 Apr 03 [Epub ahead of print]
Emma Clarebrough, Catriona Duncan, Daniel Christidis, Alain Lavoipierre, Nathan Lawrentschuk
Department of Surgery, Royal Melbourne Hospital, Parkville, Melbourne, VIC, Australia., Young Urology Research Organisation (YURO), Melbourne, Australia. ., Young Urology Research Organisation (YURO), Melbourne, Australia., Epworth Medical Imagig, Epworth Freemasons Hospital Melbourne, Melbourne, VIC, Australia., Department of Urology, Austin Health, Heidelberg, Melbourne, VIC, Australia.